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Summary 
Nitric oxide (NO)  is a major effector molecule in the destruction of tumor cells by activated 
macrophages. However, in many cases,  developing neoplasms appear to be capable of impair- 
ing steps in the complex process leading to NO production as a means of avoiding immune de- 
struction.  After  activation  with  lipopolysaccharide  (LPS),  peritoneal-ehcited  macrophages 
(PEM)  from mice bearing mammary tumors display alterations in their ability to lyse tumor 
cells due to reduced production of NO. In contrast, when these same cells are stimulated with 
LPS in combination with interferon ~/(IFN-~/), they are able to produce NO and lyse targets at 
normal levels. Since tumor-associated macrophages are intimately associated with the cells  of 
the developing tumor, their ability to produce NO and lyse tumor targets is likely to be more 
relevant to controlling tumor growth. This population of macrophages exhibited a more pro- 
found inability to produce NO and lyse targets and, unlike the PEM, was not able to upregu- 
late these functions even when treated with combinations of LPS and IFN-~. Northern  and 
Western blots revealed that inducible nitric oxide synthase (iNOS)  mRNA and protein levels 
correlated directly with the ability of each macrophage population to produce NO,  and the 
levels of these macromolecules were altered sufficiently in tumor bearers' macrophages to ac- 
count for the diminished NO production described. These results indicate that a spatial gradi- 
ent of suppression of macrophage cytolytic activity and iNOS  expression exists in mammary 
tumor-bearing mice, whereby macrophages from within the tumor exhibit a more pronounced 
suppression than the more distally located PEM. This suppression may be due to proximity of 
the macrophages to the developing tumor, macrophage maturational state, or both. 
T 
he activation of macrophages for tumoricidal activity 
is  a  complex process that  can be  accomplished with 
combinations of bacterial cell wall products, including LPS 
and cytokines, such as IFN-'y (1-3).  Once activated, mac- 
rophages are able to produce a variety of factors capable of 
lysing tumor cells.  These factors include  TNF--~, reactive 
oxygen  intermediates,  and  nitric  oxide  (NO) 1  (1,  4,  5). 
Under  normal  conditions,  the  integrity  of this  complex 
process  is  maintained,  but  during  tumor progression  these 
mechanisms may become altered,  resulting in the inability 
of the macrophages to lyse tumor cells. Several laboratories 
have  demonstrated  an  inhibition  of macrophage-mediated 
1Abbreviations used in this paper: iNOS, inducible nitric oxide synthase; 
NO, nitric oxide; N-PEM, PEM from normal mice; PEM, peritoneal- 
ehcited macrophages; TAM, tumor-associated macrophages; TB-PEM, 
PEM from  tumor-bearing  mice. 
cytotoxicity in  the  presence  of developing tumors  (6-9). 
Our previous studies  revealed that,  when  compared with 
peritoneal-ehcited macrophages (PEM)  from normal mice 
(N-PEM),  the  lyric activity of PEM  from tumor-bearing 
mice  (TB-PEM)  is  altered in  response to  LPS  activation; 
however, this defect is not due to impaired target binding 
or to decreased production of TNF-c~ or H202 (8). In con- 
trast, we have found that the production of NO by tumor 
bearers' PEM  is inhibited  in  a  manner that parallels  their 
observed loss of cytotoxicity (8).  Furthermore, when these 
same  cells  are  stimulated  with  LPS  in  combination  with 
IFN-~, they are able to recover the capacity to both pro- 
duce NO and lyse tumor targets to near normal levels (8, 9). 
Macrophage production of NO is regulated at the tran- 
scriptional level of the enzyme inducible nitric  oxide syn- 
thase (iNOS) and is induced most efl]ciendy in response to 
LPS and IFN-~/(10, 11).  Once produced, NO diffuses into 
adjacent cells  and inactivates key enzymes involved in cell 
metabohsm,  eventually leading  to  cell  stasis  or death  (12, 
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tumor growth on the production of NO  by macrophages 
have not been elucidated. 
In the studies reported herein, we examined the molecu- 
lar events preceding the production of NO by PEM from 
both  normal  and  tumor-bearing  mice,  and  by  tumor- 
associated macrophages (TAM). Our data indicate that the 
reduced  capacity  of tumor-bearers'  macrophages  to  pro- 
duce  NO  and lyse  tumor targets  results from  diminished 
iNOS expression, and that this defect is quantitatively and 
qualitatively more profound in macrophages directly asso- 
ciated with the tumor. 
Materials and Methods 
Mice and Tumors.  Male and female 8-12-wk-old BALB/c mice, 
maintained by brother-sister matings in our facilities, were used 
in all experiments. The D1-DMBA-3 mammary adenocarcinoma 
was  derived in a BALB/c mouse from a nonviral, carcinogen- 
induced, preneoplastic  alveolar nodule treated with 7,12-dimeth- 
ylbenzanthracene (14). This  tumor is  transplanted in BALB/c 
mice by s.c. injection of 106 tumor cells. The in vitro DA-3 cell line 
was derived from the in vivo D1-DMBA-3 mammary tumor (15). 
Reagents.  RPMI 1640 supplemented with 100 U of penicillin, 
100 I-tg/ml of streptomycin, 5 ￿  10 -5 M 2-ME, 2 mM c-gluta- 
mine, 1% nonessential amino acids, 1% sodium pyruvate, and 10% 
FCS (all from GIBCO BRL, Gaithersburg,  MD) was used as cul- 
ture media in all experiments. Escherichia coli 055:B5  LPS (Difco 
Laboratories, Detroit, MI), rrnlFN-~/(Genzyme  Corp.,  Cambridge, 
MA),  N~  and  MTT  (3-[4,5-Dimeth- 
ylthiazol-2-yl]-2,5-diphenyltetrazolium  bromide) (Sigma Chemi- 
cal Co., St. Louis, MO) were employed as described. 
Preparation of PEM.  Normal  and  4-wk-old  tumor-bearing 
mice were injected with  1.5 ml i.p.  of 3% thioglycolate  (Difco 
Laboratories).  On day 4, the PEM were obtained by peritoneal 
lavage as previously described (16). 
Preparation of TAM.  TAM were isolated based on previously 
described protocols  (17, 18). Briefly, tumors obtained 4 wk after 
transplantation were aseptically removed and minced into 1-2- 
ram  3 pieces of tissue. These pieces were then treated twice with a 
cocktail  of 0.3% collagenase and 10% DNase  (both from Boeh- 
ringer Mannheim Corp.,  Indianapolis, IN) at 37~  for 20  min. 
The resultant supematant containing the disaggregated  cells was 
then  spun  through  a  Nycodenz  density  gradient  (1.10  g/ml; 
GIBCO BRL)  (19) at 4~  to remove dead cells and debris. The 
live cells were washed twice and the adherent population was ob- 
tained after a 2-h incubation on 10-cm plastic dishes at 37~  and 
5% CO2 (20). Using a hematoxylin and eosin (H&E) differential 
stain (Diff-Quick; Baxter Diagnostics, Inc., McGraw Park, IL), we 
have shown that >95% of this adherent population were cells of 
the monocyte/macrophage lineage,  and >87% were nonspecific 
esterase positive  (Sigula Chemical Co.). Contaminating  cells con- 
sisted of, in order of frequency, lymphocytes  (<~3%), blasts (~<2%), 
and unidentified cells (~< 1%). Viability remained >95% by trypan 
blue exclusion. After adherence, TAM to be used in bioassays 
were placed on ice for 10 min in RPMI 1640, gently scraped free 
of the plate  (20), and resuspended  at the appropriate  concentra- 
tion. 
Nitrite Determination.  Peritoneal and tumor-associated macro- 
phages were isolated and adhered in 96-well flat-bottom plates (Co- 
star Corp., Cambridge, MA)  at 1.5  ￿  105 cells/well.  Cells were 
then cultured for 22-24 h 37~  and 5% CO 2 in plain media or 
media containing LPS alone or in combination with IFN-',/. Ni- 
trite  concentrations in cell-free  supernatants  were  measured by 
the  Griess  reaction  according  to  the  protocol  of Stuehr  and 
Nathan (12), and serve as a reflection of NO production. 
Tumor Target Cytotoxicity Assay.  Cytolytic capacity was mea- 
sured  after nitrite determination by the release of SlCr from la- 
beled syngeneic DA-3 or allogeneic P-815 tumor targets as previ- 
ously described (8). 
Phagocytosis of Latex Beads.  Isolated  peritoneal  and  tumor- 
associated macrophages  were  adhered at  3  ￿  105  cells/well for 
2 h  to  glass coverslips.  The  cells were  then washed  twice,  and 
cultured for 1 h in supplemented RPMI  1640 containing ~10  v 
latex beads (Sigma Chemical Co.). Excess beads were washed free 
and the live macrophages were examined under an oil immersion 
objective for phagocytosis  of the beads.  100 cells were counted 
from each sample, and data were expressed as the percentage of 
cells containing  beads. 
Mitochondrial Dehydrogenase Activity.  Mitochondrial dehydroge- 
nase activity was assessed by MTT assay as previously described (16). 
IL-6 ELISA.  Production of IL-6 by peritoneal and tumor- 
associated macrophages  was determined by ELISA  (Mouse  1L-6 
MiniKit; Endogen, Cambridge, MA)  according to the manufac- 
turer's lot-specific instruction. 
Western Hybridizations.  Macrophages  were  plated  on  10-cm 
plastic dishes and cultured for 24 h in media alone or media con- 
taining LPS or LPS and IFN-~. Total cellular protein was isolated 
as previously described  (16). Protein concentration was normal- 
ized by comparison with BSA standards  (Sigma Chemical Co.). 
The proteins were resolved  on 5%  SDS-PAGE and transferred 
onto 0.45-~m nitrocellulose membranes (Costar  Corp.).  Mem- 
branes were  probed  with  mouse  IgG  monoclonal anti-mouse 
iNOS (Transduction Laboratories,  Lexington, KY;  1:1,000 dilu- 
tion) at room temperature for  1 h. Protein was visualized by the 
electrochemiluminescence method (ECL; Amersham Corp., Ar- 
lington Heights,  IL) according to the manufacturer's instructions. 
Northern Hybridizations.  Macrophages were plated and activated 
as described for Western hybridizations,  and cells were lysed at the 
times indicated in the figure legends. Total RNA was isolated by 
Trizol reagent (GIBCO BRL) according to the manufacturer's in- 
structions.  R.NA samples  (15  p,g) were  electrophoresed,  trans- 
ferred, and hybridized based on methods described by Fourney et al. 
(21). iNOS cDNA probes,  a generous gift from Drs. Snyder and 
C.J.  Lowenstein (Johns Hopkins University School  of Medicine, 
Baltimore,  MD), were radiolabeled with [32p]dCTP (3,000  [zCi/ 
mmol; New England Nuclear, Boston, MA)  by random primer 
labeling (Prime-a-gene; Amersham Corp.). Blots were hybridized 
at 42~  overnight and then washed at 65~  for 1 h. Labeled blots 
were  autoradiographed  with  Hyperfilm  (Amersham  Corp.)  at 
-70~  for the times indicated in each experiment. [3-actin levels 
were  similarly  examined,  and  served  as  controls  to  normalize 
tLNA quantity. 
Densitometric Quantification q[Blots.  Images were scanned on a 
Scanmaster  3+  scanner (Howtek,  Inc. Hudson, NH).  Band in- 
tensity was assessed on a Sun Sparcstation  5 computer (Sun Mi- 
crosystems  Computer Corp.,  Mountain View,  CA)  with  Bio- 
Image Whole Band Analyzer software (BioImage  Systems Corp., 
Ann Arbor, MI). In Northern analysis, band intensity was nor- 
realized  to control ~-actin signals to account for any differences 
in total  RNA content for each  sample.  Band intensity was  re- 
ported in relative  densitometric units. The units were calculated 
as  a fraction  relative  to  the  maximum sample  density for  each 
blot, which was provided an arbitrary value of one. 
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In  response  to  activation  with  LPS  (10  ~g/ml),  TB- 
PEM  had  a  diminished capacity to produce NO  and lyse 
syngeneic DA-3 tumor targets when compared with N-PEM. 
In contrast, when TB-PEM were stimulated with LPS (10 
~g/ml) in combination with IFN-~/(10 or 50 U/m1), they 
were  able to produce  NO  and lyse targets at near normal 
levels (Fig. 1). IFN-'y alone did not induce NO  production 
or  cytolytic activity in  these  cells.  Moreover,  NG-mono  - 
methyl-L-arginine  (an  inhibitor  of  NO  production) 
blocked cytolytic activity, indicating that NO  is the major 
mediator  of tumoricidal  function  (data  not  shown).  Be- 
cause of their proximity to the developing tumor, we eval- 
uated the ability of TAM to perform these functions. Upon 
stimulation with LPS, TAM  were  unable to produce NO 
or lyse DA-3 targets above basal levels and, further, TAM 
failed to  exert  these  functions  even  after  the  addition  of 
IFN-'y (Fig.  1).  A  similar reduction  in lytic capacity was 
exhibited toward allogeneic P815 routine mastocytoma tar- 
gets by TAM (data not shown). 
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Further analyses revealed that the enzymatic process em- 
ployed to isolate TAM from the tumor tissue is unlikely to 
have contributed to the unresponsiveness of these macro- 
phages as this procedure had no  effect on NO  production 
or cytolytic activity by either N-PEM or TB-PEM (data not 
shown). Additionally, the TAM were morphologically and 
functionally similar to PEM from normal and tumor-bear- 
ing mice (Table 1). Although the TAM exhibited a dimin- 
ished capacity to produce NO  and lyse targets for up to at 
least 72 h  in culture, they retained other complex functions 
such as adherence to plastic, phagocytosis of  latex beads, mito- 
chondrial dehydrogenase activity, and the ability to exclude 
trypan blue during this same time period. The TAM were also 
able to produce IL-6, as measured by ELISA, at comparable 
levels to  those produced by similarly treated N-PEM  and 
TB-PEM  (Table  2).  These  data  indicate  that  the  defects 
noted in the TAM were specific. 
Western blots were performed to evaluate the expression 
of iNOS  protein  in  PEM  and  TAM.  As  seen  in  Fig.  2, 
iNOS protein could not be detected in unstimulated PEM 
or  TAM.  However,  when  stimulated with  LPS  (10  Ixg/ 
ml),  N-PEM  produced  substantial  quantities  of the  en- 
zyme, whereas levels of this protein remained undetectable 
in  TB-PEM  and  TAM.  After  stimulation  with  LPS  (10 
Ixg/ml) and IFN-~/(50 U/ml) in combination, both popu- 
lations of PEM produced approximately equal and high lev- 
els of the  enzyme  whereas  iNOS  protein levels remained 
undetectable in TAM. Furthermore, treatment with 50 U/rnl 
of IFN-'y alone  did not  produce  detectable  quantities  of 
iNOS protein in any population (data not shown). 
Northern  hybridizations  were  performed  to  evaluate 
iNOS mP,  NA accumulation in PEM and TAM. After acti- 
vation  with  LPS  (10  Ixg/ml),  detectable  levels  of iNOS 
Table 1.  Characteristics  of Normal and Tumor Bearers' Peritoneal 
Macrophages and TAM 
Percent 
Properties  N-PEM  TB-PEM  TAM 
Viability by trypan blue exclusion  95  97  96 
Adherence to plastic  100  100  100 
Macrophages/monocytes by 
H&E staining  94  97  95 
Nonspecific esterase positive  93  94  87 
Phagocytosis of latex beads  96  95  97 
Activity of mitochondrial 
dehydrogenases*  100  101  99 
Figure 1.  NO production and cytolytic capacity are altered in tumor 
bearers' macrophages. N-PEM (O), TB-PEM  (I), and TAM(A) were 
cultured at 1.5 ￿  105 cells/well for 24 h in media containing LPS (10 lig/ 
ml) alone or in combination with varying concentrations oflFN-~ (10 or 
50 U/ml). NO production (A) was evaluated in cell supernatants as nitrite 
by the  Griess reaction.  Cytotoxic  activity (B)  was  measured as SlCr- 
release by syngeneic DA-3 targets. Values represent mean +- SD of tripli- 
cate samples  from a representative experiment. 
N-PEM, TB-PEM, and TAM were isolated as described in Materials 
and Methods, and then adhered to plastic for 2 h before washing to re- 
move  nonadherent  cells. The  adherent  cells were  then  cultured  in 
complete  media overnight  before  morphologic  and functional assess- 
ment.  These results represent data obtained from a representative ex- 
periment. 
*Expressed as a percentage of N-PEM formazan absorbance. 
1325  DiNapoli et al. Table 2.  IL-6 Production by Normal and Tumor Bearers' 
Peritoneal Macrophages and TAM 
IL-6 (pg/ml) _  SD 
Population  Unstimulated  LPS (10 otg/rnl) 
N-PEM  42.7 +  3.9  7,587.4  •  163.9 
TB-PEM  35.4 •  0.7  7,077.5  +  237.9 
TAM-1  44.4 •  5.1  5,664.2  •  195.7 
TAM-2  41.1  •  2.6  9,154.0  •  197.3 
N-PEM, TB-PEM, and two separate populations of TAM were iso- 
lated as described in Materials and Methods.  The  N-PEM and TB- 
PEM were then subjected to the same enzymatic protocol employed to 
obtain the TAM. Cells were plated in 96-well microtiter plates at 1.5 
￿  105 cells/well, and cultured in plain media or media containing LPS 
(10 txg/ml) for 18 h. IL-6 levels were evaluated by ELISA, and results 
represent mean +  SD of triplicate samples from a representative exper- 
iment. 
message appeared in PEM from both types of mice by 4  h 
and reached maximum levels by 8  h  (Fig. 3  A). After this 
time,  the  levels  of iNOS  mRNA  began  to  decline.  Al- 
though the pattern of iNOS mRNA  accumulation in TB- 
PEM resembles that seen in N-PEM,  the quantities of this 
message  consistently remained  depressed in  the  TB-PEM 
and became nearly undetectable by 24 h. At similar autora- 
diograph  times,  iNOS  mRNA  could  not  be  observed in 
TAM at any time point after stimulation with LPS. 
Similar experiments were performed after stimulation of 
PEM and TAM with LPS (10 ~g/ml) in combination with 
IFN-~  (50  U/ml)  (Fig.  3  B).  iNOS  mRNA  levels  in- 
creased more rapidly and remained elevated longer in PEM 
from normal and tumor-bearing mice when compared with 
the induction observed subsequent to stimulation with LPS 
alone.  More  importantly,  the  TB-PEM  were  able  to  re- 
cover the  accumulation  of iNOS  mRNA  to  near normal 
levels  after  receiving the  stronger  signal  provided by  the 
combination of LPS and IFN-y. Additionally, a significant 
amount of this message remained in PEM from normal and 
tumor-bearing mice at 24 h  after stimulation. Again, TAM 
failed to  accumulate  detectable levels of iNOS  mRNA  at 
all time points. 
Discussion 
Activated macrophages play an important role in the de- 
struction of a variety of tumor cells (1-5,  11-13); however, 
the  integrity  of the  pathways  for  macrophage  activation 
must be preserved for NO  production and cytolytic activity 
to be maintained. In many cases, developing neoplasms ap- 
pear  to  be  capable  of impairing steps  in  this  process  as  a 
means of avoiding immune destruction (6-9). 
Here  we  present evidence that  a  progressively growing 
mammary  tumor  can  suppress  host  macrophage  cytolytic 
activity through  alterations in  NO  production as a  conse- 
quence  of reduced  iNOS  expression.  Alterations in  NO 
production and cytolytic activity became more profound in 
PEM with progression of the tumor  (data not shown)  and 
were most severe in macrophages isolated directly from the 
tumor.  TAM  were  unable  to  produce significant amounts 
of NO  or lyse targets regardless of stimulation employed. 
Our  data suggest that  the  enzymatic process employed to 
obtain the TAM was not responsible for these alterations, and 
further  experiments with  resident peritoneal macrophages 
suggest that the elicitation process also was not involved in 
the  functional  differences  noted  between  the  PEM  and 
TAM (data not shown). Despite the fact that TB-PEM and 
TAM  exhibited alterations in their ability to produce NO 
and lyse targets,  these  cells remained fully capable of per- 
forming other complex functions, including the production 
and release of IL-6. These data indicate that the alterations 
leading to  the  inhibition in  NO  production  and  cytolytic 
activity were  not  occurring pervasively within  the  tumor 
bearers'  macrophages,  but  rather  were  affecting  specific 
functions. 
Figure  2.  iNOS  protein  lev- 
els are altered in tumor bearers' 
macrophages.  N-PEM,  TB- 
PEM,  and  TAM  were  cultured 
for 24 h in plain media or media 
containing LPS (10 ~g/ml) alone 
or in  combination  with  IFN-'y 
(50 U/ml). Total cellular protein 
was  isolated  and  the  levels of 
iNOS  protein  were  assessed by 
Western analysis.  Blots were ex- 
posed for 90 s to allow optimum 
visualization of bands. Levels of 
iNOS protein are depicted in the 
accompanying histogram as den- 
sitometric  units relative  to  the 
maximum iNOS signal obtained 
for this blot. 
1326  Reduced Inducible Nitric Oxide Synthase in Tumor Bearers' Macrophages Figure  3.  Accumulation  of 
iNOS  mtLNA  in  PEM  and 
TAM in response to LPS alone 
or in combination with  IFN-~. 
N-PEM,  TB-PEM,  and  TAM 
were cultured in media contain- 
ing LPS (10 ~g/ml) alone (A) or 
in combination with IFN-~ (50 
U/ml)  (/3). Total  cellular RNA 
was  isolated at  the  times  indi- 
cated,  and  the  levels of iNOS 
mlLNA were assessed  by North- 
ern  analysis. Blots  from  cells 
stimulated  with  LPS  (A)  were 
autoradiographed  for  8  h, 
whereas those from cells stimu- 
lated with  LPS  and  IFN-'y (B) 
were autoradiographed for 2 h to 
prevent  overexposure.  After 
densitometric  analysis, iNOS 
levels were  normalized to  their 
respective  J3-actin controls  and 
presented  in  the  accompanying 
histograms  as  densitometric 
units  relative  to  the  maximum 
iNOS signal for each blot. 
Because  of the  intimate  association  of TAM  with  the 
cells of the developing tumor,  TAM are believed to play a 
crucial  role  in  regulating  tumor  growth  (22-24).  In  this 
system, the almost complete loss of the capacity of TAM to 
produce NO  and lyse tumor targets may explain the pro- 
gressive nature  of this mammary tumor.  In support  of the 
significance of NO  production by infiltrating macrophages 
in controlling tumor growth, Yim et al. (25) have demon- 
strated that the production of NO  by TAM leads to the in 
vivo regression of ultraviolet-induced murine skin cancers. 
Similarly, Umansky et al. (26) have recently reported that a 
transient arrest in T  lymphoma metastasis was accompanied 
by an increase in NO  production by liver Kupffer cells and 
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splenic macrophages,  whereas  metastatic  expansion  corre- 
lated with a reduction in NO  production. 
Our  results  concur  with  those  of Mills et  al.  (27)  and 
Murata et al.  (28), who have recently demonstrated a sup- 
pression of NO  production in intratumor macrophages and 
cerebral endothelial cells, respectively, associated with  the 
growth of tumor cells. In addition, evidence that NO  pro- 
duction  by  macrophages  within  tumors  may  be  reduced 
was  suggested as  early as  1977,  when  Spitalny and North 
(29) noted that tumors act as privileged sites for the growth 
of Listeria monocytogenes, a bacteria that is now known to be 
susceptible to  killing by macrophage-produced  NO  (30). 
However, the molecular events leading to the reduced pro- duction of NO in response to tumor growth have not been 
previously evaluated. 
In these studies, Northern and Western blots from tumor 
bearers' macrophages revealed that iNOS mRNA  and pro- 
tein levels correlated directly with the abihty of each mac- 
rophage population  to both produce  NO  and  lyse  tumor 
targets.  Furthermore,  the addition of exogenous L-arginine 
had no effect on NO  production  (data not shown),  ruhng 
out the possibility that diminished  substrate  concentrations 
were contributing to the observations. However, effects on 
the availability of cofactors cannot be dismissed. 
Using immunohistochemistry,  Thomsen et al.  (31)  have 
recently demonstrated an increase in iNOS protein in mac- 
rophages within sections of human breast cancer. Although 
our data contrast with these results, we have found that, af- 
ter prolonged exposure of both Western and Northern hy- 
bridizations,  trace quantities  of iNOS protein and mP,.NA, 
respectively,  are  detectable  in  TAM  from our  system.  In 
addition, where detectable,  these molecules appear to be of 
identical size to those from N-PEM, suggesting that the ba- 
sis for the altered levels of iNOS protein is more likely to 
be  reduced  synthesis  rather  than  increased  degradation  of 
the protein,  and that truncation or incorrect splicing of the 
mRNA has not occurred and is therefore not likely to have 
contributed to the reduced iNOS protein levels. 
We have  demonstrated  that  qualitative  and  quantitative 
differences exist in the alterations noted in TAM and TB- 
PEM. There appears to be a spatial  gradient of suppression of 
macrophage cytolytic activity and iNOS expression, whereby 
macrophages  isolated  directly  from  the  tumor  exhibit  a 
more profound suppression  than  the  more distally located 
PEM.  In the  tumor microenvironment,  TAM may be af- 
fected  by higher  concentrations  of tumor-derived  or  tu- 
mor-induced factors, or by cells  present within the tumor. 
Alternatively,  TAM  dysfunction may be  secondary to the 
maturational stage of these cells.  TAM are believed to arise 
from blood monocytes that are recruited into the tumor by 
tumor factors (23).  The fact that the TAM do not recover 
their ability to produce NO  or lyse targets even after sev- 
eral days in culture suggests that cells  or factors within  the 
tumor may have induced the infiltrating monocytes to have 
remained in or to have differentiated into a state less  capa- 
ble of responding to LPS and/or IFN-~/.  In support of this 
idea,  Moore  and  McBride  (32)  have  hypothesized  that 
within  the  tumor  microenvironment,  infiltrating  mono- 
cytes  may  be  unable  to  fully  mature  into  tissue  macro- 
phages  capable  of lysing  targets.  Moreover,  it  has  been 
demonstrated  that  the  less  mature  WEHI-3  macrophage 
cell line similarly does not respond to IFN-y for the induc- 
tion  of cytolytic  activity  (33),  and  that  genes  containing 
IFN-stimulated response  element  or gamma-activation site 
binding  motifs  within  their  promoter  region  are  induced 
only in the more mature RAW 264.7 macrophage cell line 
(33, 34).  TAM isolated from a murine B16 melanoma dis- 
play a similar, less mature response to IFN-',/as observed in 
the  WEHI-3  cells;  Paulnock  (35)  suggests  that  macro- 
phages recruited during tumor growth may be under regu- 
latory constraints which limit their activation to the tumor- 
icidal  state.  Lastly,  conditions  of  hypoxia  and  nutrient 
depletion  within  the  tumor may further reduce  the  effec- 
tiveness of the macrophages to lyse cancerous cells,  allow- 
ing the tumor to grow progressively despite the presence of 
TAM  (24).  Our results  indicate  that  the  reduced  tumori- 
cidal capacity of macrophages from mammary tumor-bear- 
ing  mice  results  from  diminished  iNOS  expression,  and 
that  this  defect  is  more  pronounced  in  macrophages  di- 
rectly  isolated  from  the  tumor.  This  inability  of tumor- 
infiltrating  macrophages  to  produce  NO  and  lyse  tumor 
cells  may contribute  to the  continued development of the 
tumor and the eventual subversion of the host. 
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